Ib Jarle Christensen
About
Ib Jarle Christensen is a scholar working on Oncology, Cancer Research and Molecular Biology.
According to data from OpenAlex, Ib Jarle Christensen has authored 446 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 207 papers in Oncology, 138 papers in Cancer Research and 129 papers in Molecular Biology. Recurrent topics in Ib Jarle Christensen's work include Protease and Inhibitor Mechanisms (67 papers), Peptidase Inhibition and Analysis (60 papers) and Genetic factors in colorectal cancer (46 papers). Ib Jarle Christensen is often cited by papers focused on Protease and Inhibitor Mechanisms (67 papers), Peptidase Inhibition and Analysis (60 papers) and Genetic factors in colorectal cancer (46 papers). Ib Jarle Christensen collaborates with scholars based in Denmark, United States and United Kingdom. Ib Jarle Christensen's co-authors include Lars L. Vindeløv, Nis I. Nissen, Hans Jørgen Nielsen, Nils Brünner, Claus Høgdall, Julia S. Johansen, Estrid Høgdall, Gunilla Høyer‐Hansen, Paul A. Price and Nils Brünner and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The EMBO Journal.
In The Last Decade
Ib Jarle Christensen
437 papers receiving 14.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ib Jarle Christensen Denmark | 61 | 5.6k | 5.4k | 4.0k | 2.5k | 2.0k | 446 | 15.3k | ||
| David W. Hedley Canada | 66 | 6.6k 1.2× | 6.9k 1.3× | 5.1k 1.3× | 1.2k 0.5× | 2.9k 1.4× | 322 | 17.2k | ||
| Christian Marth Austria | 61 | 5.3k 0.9× | 5.8k 1.1× | 2.8k 0.7× | 1.8k 0.7× | 1.3k 0.6× | 411 | 14.0k | ||
| Andreas Jung Germany | 55 | 7.5k 1.3× | 6.3k 1.2× | 3.0k 0.8× | 1.4k 0.6× | 2.3k 1.1× | 260 | 13.7k | ||
| Ernst Lengyel United States | 65 | 5.7k 1.0× | 10.6k 2.0× | 7.8k 2.0× | 2.4k 1.0× | 1.4k 0.7× | 190 | 18.7k | ||
| Andres J. Klein–Szanto United States | 83 | 7.0k 1.3× | 12.0k 2.2× | 4.9k 1.2× | 1.7k 0.7× | 2.6k 1.3× | 383 | 21.3k | ||
| Lucio Miele United States | 79 | 5.4k 1.0× | 10.8k 2.0× | 3.6k 0.9× | 2.9k 1.2× | 1.8k 0.9× | 276 | 18.2k | ||
| Ben Davidson Norway | 63 | 3.8k 0.7× | 6.9k 1.3× | 3.6k 0.9× | 1.6k 0.6× | 2.2k 1.1× | 420 | 13.7k | ||
| Kathleen R. Cho United States | 66 | 6.3k 1.1× | 10.5k 1.9× | 4.8k 1.2× | 2.0k 0.8× | 1.6k 0.8× | 152 | 18.8k | ||
| Joseph R. Testa United States | 83 | 5.4k 1.0× | 14.1k 2.6× | 3.9k 1.0× | 1.9k 0.8× | 5.9k 2.9× | 347 | 24.5k | ||
| Jacqueline Whang‐Peng Taiwan | 63 | 5.0k 0.9× | 5.6k 1.0× | 1.8k 0.4× | 1.6k 0.6× | 3.1k 1.5× | 319 | 15.0k |
Countries citing papers authored by Ib Jarle Christensen
Since
Specialization
Citations
This map shows the geographic impact of Ib Jarle Christensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ib Jarle Christensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ib Jarle Christensen more than expected).
Fields of papers citing papers by Ib Jarle Christensen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ib Jarle Christensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ib Jarle Christensen. The network helps show where Ib Jarle Christensen may publish in the future.
Co-authorship network of co-authors of Ib Jarle Christensen
This figure shows the co-authorship network connecting the top 25 collaborators of Ib Jarle Christensen. A scholar is included among the top collaborators of Ib Jarle Christensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ib Jarle Christensen. Ib Jarle Christensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Schejbel, Lone, Anne Ortved Gang, Ib Jarle Christensen, et al.. (2024). TP53 Mutation Is the Only Robust Mutational Biomarker for Outcome Found in a Consecutive Clinical Cohort of Real‐Word Patients With Primary Large B‐Cell Lymphoma. European Journal Of Haematology. 114(3). 573–579.
2.
Henriksen, O., Benedikte Hasselbalch, Hans Skovgaard Poulsen, et al.. (2024). Magnetic resonance imaging and o -(2-[18F]fluoroethyl)-l -tyrosine positron emission tomography for early response assessment of nivolumab and bevacizumab in patients with recurrent high-grade astrocytic glioma. Neuro-Oncology Advances. 6(1). vdae178–vdae178.
3.
Draghi, Arianna, Annie Borch, Filip Mundt, et al.. (2024). Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways. Cancer Immunology Research. 12(9). 1202–1220.
4.
Nielsen, Boye Schnack, Ib Jarle Christensen, Ebbe Langholz, et al.. (2023). MUCOSAL EXPRESSION OF GENES PI3, ANXA1, AND VDR DESCRIMINATES CROHNS DISEASE FROM ULCERATIVE COLITIS IN INFLAMMATORY BOWEL DISEASE PATIENTS. Inflammatory Bowel Diseases. 29(Supplement_1). S13–S13.
5.
Christensen, Ib Jarle, Eva Balslev, Ann Knoop, et al.. (2019). Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay. Breast Cancer. 27(2). 266–276.
6.
Hentze, Julie L., Guy Wayne Novotny, Vibeke Ravn, et al.. (2019). Optimized Biobanking Procedures for Preservation of RNA in Tissue: Comparison of Snap-Freezing and RNAlater-Fixation Methods. Biopreservation and Biobanking. 17(6). 562–569.
7.
Rask, Lene, Claus Høgdall, Susanne K. Kjær, et al.. (2019). Association of CD31 and p53 With Survival of Ovarian Cancer Patients. Anticancer Research. 39(2). 567–576.
8.
Christensen, Ib Jarle, Eva Balslev, Ann Knoop, et al.. (2018). Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study. Breast Cancer Research and Treatment. 172(2). 391–400.
9.
Bønnelykke‐Behrndtz, Marie Louise, Laura Ward, J. Collin, et al.. (2015). The wound inflammatory response exacerbates growth of pre‐neoplastic cells and progression to cancer. The EMBO Journal. 34(17). 2219–2236.
10.
Christensen, Ib Jarle, Ben Vainer, Lars Bo Svendsen, et al.. (2015). The Prognostic and Predictive Value of Soluble Type IV Collagen in Colorectal Cancer: A Retrospective Multicenter Study. Clinical Cancer Research. 22(10). 2427–2434.
11.
Illemann, Martin, Gunilla Høyer‐Hansen, Ib Jarle Christensen, et al.. (2015). Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 33(4). 165.e15–165.e24.
12.
Prahm, Kira Philipsen, Mona Aarenstrup Karlsen, Estrid Høgdall, et al.. (2014). The prognostic value of dividing epithelial ovarian cancer into type I and type II tumors based on pathologic characteristics. Gynecologic Oncology. 136(2). 205–211.
13.
Christensen, Ib Jarle, Gunilla Høyer‐Hansen, Keld Danø, et al.. (2011). Urokinase receptor forms in serum from non-small cell lung cancer patients: Relation to prognosis. Lung Cancer. 74(3). 510–515.
14.
Høgdall, Estrid, Lise Christensen, Susanne K. Kjær, et al.. (2010). Limited prognostic value of tissue protein expression levels of BCl‐2 in Danish ovarian cancer patients: from the Danish ‘MALOVA’ ovarian cancer study. Apmis. 118(8). 557–564.
15.
Petri, Anette Lykke, Anja Hviid Simonsen, Estrid Høgdall, et al.. (2010). Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis. PROTEOMICS - CLINICAL APPLICATIONS. 4(3). 304–314.
16.
Hénic, Emir, Christer Borgfeldt, Ib Jarle Christensen, Bertil Casslén, & Gunilla Høyer‐Hansen. (2008). Cleaved Forms of the Urokinase Plasminogen Activator Receptor in Plasma Have Diagnostic Potential and Predict Postoperative Survival in Patients with Ovarian Cancer. Clinical Cancer Research. 14(18). 5785–5793.
17.
Svendsen, Mads Nordahl, Henriette Ytting, Nils Brünner, Hans Jørgen Nielsen, & Ib Jarle Christensen. (2006). Preoperative Concentrations of suPAR and MBL Proteins Are Associated with the Development of Pneumonia after Elective Surgery for Colorectal Cancer. Surgical Infections. 7(5). 463–471.
18.
Nielsen, Hans Jørgen, Ib Jarle Christensen, & Nils Brünner. (2005). [Serological markers of colorectal cancer].. PubMed. 167(44). 4163–7.
19.
Nielsen, Hans Jørgen, et al.. (1999). Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. The Journal of Pathology. 189(4). 487–495.
20.
Suciu, Stefan, R. Sylvester, Peter Iversen, Ib Jarle Christensen, & L. Denis. (1993). Comparability of prostate trials. Cancer. 72(S12). 3841–3846.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by David W. Hedley Breakdown of academic impact, for papers by Christian Marth Breakdown of academic impact, for papers by Andreas Jung Breakdown of academic impact, for papers by Ernst Lengyel Breakdown of academic impact, for papers by Andres J. Klein–Szanto Breakdown of academic impact, for papers by Lucio Miele Breakdown of academic impact, for papers by Ben Davidson Breakdown of academic impact, for papers by Kathleen R. Cho Breakdown of academic impact, for papers by Joseph R. Testa Breakdown of academic impact, for papers by Jacqueline Whang‐Peng